JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB141574

BAY 11-7085, Irreversible inhibitor of TNF alpha-induced IxBalpha phosphorylation

Be the first to review this product! Submit a review

|

(2 Publications)

MW 249.33 Da, Purity >99%. Irreversibly inhibits TNF-α-induced IxBα phosphorylation. Reduces NF-κB and adhesion molecules (IC50 = 5-10 μM). Anti-inflammatory, anti cancer and neuroprotective agent in vivo.

View Alternative Names

3dopamine receptor, AHD2, AI838772, AL1A1_HUMAN, ALDC, ALDH 1, ALDH 11, ALDH class 1, ALDH, liver cytosolic, ALDH-E1, ALHDII, AW493413, Acetaldehyde dehydrogenase 1, Aldehyde dehydrogenase, Aldehyde dehydrogenase 1 family member A1, Aldehyde dehydrogenase 1 soluble, Aldehyde dehydrogenase 1A1, Aldehyde dehydrogenase cytosolic, Aldehyde dehydrogenase family 1 member A1, Aldehyde dehydrogenase liver cytosolic, C-C CKR-2, C-C chemokine receptor type 2, CCR1L, CCR2A, CCR2B, CCR2_HUMAN, CCR5L, CD192, CD192 antigen, CKR 2, CKR2A, CKR2B, CMKBR2, Chemokine C C motif receptor 2, D(3) dopamine receptor, DNA replication inhibitor, DRD3_HUMAN, Dopamine D3 receptor, Dopamine receptor D3, ETM1, FET1, FLJ11090, GEMI_HUMAN, GMNN, Geminin, Geminin DNA replication inhibitor, HEL-S-53e, MCP-1-R, MCP1 RECEPTOR, MGC104252, MGC112732, MGC2318, Monocyte Chemotactic Protein 1 Receptor, Monocyte chemoattractant protein 1 receptor, OTTHUMP00000039393, PUMB 1, RALDH 1, RP24-311F12.2, RP3 369A17.3, Retinal dehydrogenase 1, SCAN1, TYDP, TYDP1_HUMAN, Tyr-DNA phosphodiesterase 1, Tyrosyl-DNA phosphodiesterase 1, cytosolic, epididymis luminal protein 12, epididymis luminal protein 9, epididymis secretory sperm binding protein Li 53e

1 Images
Chemical Structure - BAY 11-7085, Irreversible inhibitor of TNF alpha-induced IxBalpha phosphorylation (AB141574)
  • Chemical Structure

Lab

Chemical Structure - BAY 11-7085, Irreversible inhibitor of TNF alpha-induced IxBalpha phosphorylation (AB141574)

2D chemical structure image of ab141574, BAY 11-7085, Irreversible inhibitor of TNF alpha-induced IxBalpha phosphorylation

Key facts

CAS number

196309-76-9

Purity

>99%

Form

Solid

form

Molecular weight

249.33 Da

Molecular formula

C<sub>1</sub><sub>3</sub>H<sub>1</sub><sub>5</sub>NO<sub>2</sub>S

PubChem

5353432

Nature

Synthetic

Solubility

Soluble in DMSO to 100 mM

Soluble in ethanol to 100 mM

Biochemical name

(E)-3-(4-tert-butylphenylsulfonyl)acrylonitrile

Biological description

Irreversibly inhibits TNF-α-induced IxBα phosphorylation. Reduces NF-κB and adhesion molecules (IC50 = 5-10 μM). Anti-inflammatory, anti cancer and neuroprotective agent in vivo.

Canonical smiles

CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)C=CC#N

Isomeric smiles

CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)/C=C/C#N

InChi

InChI=1S/C13H15NO2S/c1-13(2,3)11-5-7-12(8-6-11)17(15,16)10-4-9-14/h4-8,10H,1-3H3/b10-4+

InChiKey

VHKZGNPOHPFPER-ONNFQVAWSA-N

IUPAC Name

(E)-3-(4-tert-butylphenyl)sulfonylprop-2-enenitrile

style
left-column
style
left-column

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
Ambient
Appropriate long-term storage conditions
Ambient
Storage information
The product can be stored for up to 12 months
style
left-column

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

CCR2 also known as C-C chemokine receptor type 2 and Dopamine Receptor D3 (DRD3) are both G protein-coupled receptors playing critical roles in cell signaling. CCR2 with a mass of approximately 41 kDa is expressed in various tissues like the brain heart and immune cells. DRD3 with a mass of around 44 kDa is primarily present in the central nervous system especially in limbic areas and basal ganglia. TDP1 another protein target functions in DNA repair with a mass of about 68 kDa and shows expressions in most human tissues. Geminin regulates DNA replication and cell cycle weighing approximately 25 kDa and ALDH1A1 an enzyme involved in aldehyde metabolism has a mass of 55 kDa and is found in the liver kidney and several stem cells niches.
Biological function summary

CCR2 mediates immune response by binding to its ligand CCL2 and recruits monocytes to sites of inflammation. DRD3 modulates neurological and behavioral processes by inhibitory signaling in dopamine pathways. TDP1 works collaboratively with other repair proteins to correct DNA strand breaks. Geminin inhibits the replication licensing process until the appropriate phase of the cell cycle. ALDH1A1 facilitates the oxidation of retinal to retinoic acid a process essential for synthesizing bioactive molecules. These proteins impact cellular functions through their interactions in multiprotein complexes.

Pathways

CCR2 and DRD3 both play important roles in inflammation and neurotransmission pathways respectively. CCR2 is integral in the MAPK and NF-kB pathways influencing inflammatory responses and IL-6 secretion. DRD3 exerts its effects through the dopaminergic signaling pathway closely associating with other dopamine receptors and interacting with proteins like G-proteins. TDP1 participates in the base excision repair pathway while Geminin regulates the licensing of replication origins. ALDH1A1 operates within the retinoic acid biosynthesis pathway converting vitamin A derivatives.

CCR2 links to inflammatory conditions such as rheumatoid arthritis through a network including chemokine ligands and cytokines. DRD3 associates with psychiatric disorders like schizophrenia often in conjunction with other dopamine receptors. TDP1 mutations result in Spinocerebellar Ataxia with Axonal Neuropathy while Geminin misregulation may contribute to cancer by allowing unchecked DNA replication. ALDH1A1 dysregulation relates to alcohol dependence and impacts ethanol metabolism—highlighting connections with ADH proteins in alcohol oxidation and detoxification.
style
left-column
style
left-column

Product protocols

style
left-column

Publications (2)

Recent publications for all applications. Explore the full list and refine your search

International journal of molecular sciences 20: PubMed31635163

2019

Loss of Tumor Suppressor CYLD Expression Triggers Cisplatin Resistance in Oral Squamous Cell Carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Naoki Suenaga,Mimi Kuramitsu,Kanae Komure,Ayumi Kanemaru,Kanako Takano,Kazuya Ozeki,Yuka Nishimura,Ryoji Yoshida,Hideki Nakayama,Satoru Shinriki,Hideyuki Saito,Hirofumi Jono

Cell cycle (Georgetown, Tex.) 18:1001-1018 PubMed30990350

2019

NF-κB signaling pathway inhibition suppresses hippocampal neuronal apoptosis and cognitive impairment via RCAN1 in neonatal rats with hypoxic-ischemic brain damage.

Applications

Unspecified application

Species

Unspecified reactive species

Hua Fang,Hua-Feng Li,Miao Yang,Ren Liao,Ru-Rong Wang,Quan-Yun Wang,Peng-Cheng Zheng,Fang-Xiang Zhang,Jian-Ping Zhang
View all publications
style
left-column
style
left-column
style
right-column

Complementary Products

Biochemicals

AB120306

HA-1077 (Fasudil), ROCK2 inhibitor

Functional Studies - HA-1077 (Fasudil), ROCK2 inhibitor (AB120306)

  • 0
  • 0
Proteins & Peptides

AB259406

Recombinant mouse IL-4 protein (Active)

Premium Bioactive

Functional Studies - Recombinant mouse IL-4 protein (Active) (AB259406)

  • 0
  • 0
Biochemicals

AB141248

Docetaxel, Cytotoxic agent

Chemical Structure - Docetaxel, Cytotoxic agent (AB141248)

  • 0
  • 0
Biochemicals

AB120459

Mecamylamine hydrochloride, non-competitive antagonist of nicotinic receptors

Chemical Structure - Mecamylamine hydrochloride, non-competitive antagonist of nicotinic receptors (AB120459)

  • 0
  • 0

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com